epirubicin has been researched along with Colorectal Neoplasms in 37 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (2.70) | 18.7374 |
| 1990's | 13 (35.14) | 18.2507 |
| 2000's | 14 (37.84) | 29.6817 |
| 2010's | 5 (13.51) | 24.3611 |
| 2020's | 4 (10.81) | 2.80 |
| Authors | Studies |
|---|---|
| Berkel, C; Cacan, AH; Cacan, E; Caldiran, F; Canpolat, E; Citli, S; Kucuk, B; Yilmaz, E | 1 |
| Cacan, E; Ozmen, ZC | 1 |
| Brünner, N; Detlefsen, S; Nielsen, SL; Pfeiffer, P; Qvortrup, C; Stenvang, J; Tarpgaard, LS | 1 |
| Cacan, E; Kucuk, B; Yilmaz, E | 1 |
| Juang, V; Lin, GL; Lo, YL; Ting, HJ; Tseng, TC | 1 |
| Chang, CF; Lee, YK; Lin, TH; Lo, YL | 1 |
| Lin, HR; Lin, Y; Lo, YL | 1 |
| Andersen, DR; Brünner, N; Detlefsen, S; Jensen, NF; Nielsen, SL; Nygård, SB; Pfeiffer, P; Qvortrup, C; Stenvang, J; Tarpgaard, LS | 1 |
| Anita, ZB; Chandramathi, S; Kuppusamy, UR; Suresh, K | 1 |
| Harao, M; Hishinuma, S; Igarashi, S; Ishihara, M; Jindou, O; Kojima, K; Kotake, K; Matsui, T; Tsukioka, T; Yamamoto, T | 1 |
| Maruyama, S | 1 |
| Hirakawa, K; Kosaka, K; Nishihara, T; Nishino, H; Ohira, M; Yamada, N | 1 |
| Danenberg, K; Danenberg, P; Formentini, A; Hillenbrand, A; Kornmann, M; Salonga, D; Sander, S; Staib, L | 1 |
| Camaggi, CM; Cavallo, G; D'Angelo, R; Facchini, G; Fiore, F; Formato, R; Iaccarino, V; Iaffaioli, RV; Mantovani, G; Memoli, B; Petrella, G; Ricci, S; Rosato, G; Santangelo, M; Strocchi, E; Tortoriello, A | 1 |
| Chiam, AS; Huxham, LA; Kyle, AH; Minchinton, AI; Sim, DH | 1 |
| Bernardeschi, P; Cantore, M; De Simone, M; Dentico, P; Fiorentini, G; Guadagni, S; Poddie, DB; Rossi, G; Rossi, S; Tumolo, S; Valori, VM | 1 |
| Giommoni, E; Grifoni, R; Mercatelli, A; Neri, B; Pantaleo, P; Pantalone, D; Paoletti, C; Rotella, V; Taddei, A; Tonelli, P | 1 |
| Ariga, T; Kinoshita, H; Maruyama, T; Ooshima, I; Ozaki, M; Shimada, H; Shouko, T; Takeda, A; Yoshimura, S | 1 |
| Miura, T; Shinohara, K | 1 |
| Kunii, Y; Mashiko, H; Momono, S; Muto, I; Nakagawa, K; Ouchi, A; Shiiba, K; Wada, M; Yamamoto, K; Yamazaki, T | 1 |
| Hojyo, M; Hoshiya, Y; Kaneko, T; Kosaka, A; Mori, K; Ohara, M; Shikata, A; Watabiki, Y; Yamada, S; Yamamoto, N; Yamazaki, M; Yorozuya, K | 1 |
| Harada, A; Kurokawa, T; Nakao, A; Nonami, T; Takagi, H; Takeuchi, Y; Taniguch, K; Yasui, M | 1 |
| Aitini, E; Amadori, M; Bertani, M; Bezzi, A; Campo, S; Cantore, M; Cavazzini, G; Mambrini, A; Pari, F; Pulica, C; Rabbi, C; Smerieri, F; Zamagni, D | 1 |
| Beger, HG; Butzer, U; Danenberg, KD; Danenberg, PV; Kornmann, M; Leder, GH; Lenz, HJ; Link, KH; Metzger, R; Pillasch, J; Safi, F; Weindel, M | 1 |
| Baba, S; Ishida, H; Kawasaki, T; Masutani, S; Miya, A; Morimoto, O; Satomi, T; Shiozaki, K; Tatsuta, M; Tsuji, Y | 1 |
| Borden, EC; Green, M; Haller, DG; Marsh, JC; Rosenthal, MA; Wiernik, P | 1 |
| Hoshiya, Y; Kosaka, A; Mori, K; Ohara, M; Oohata, K; Shikata, A; Tukamoto, H; Watabiki, Y; Yamada, S; Yamazaki, M; Yoneyama, Y | 1 |
| Armand, JP; Evans, TR; Seymour, L | 1 |
| Danenberg, PV; Kornmann, M; Leder, GH; Link, KH; Pillasch, J | 1 |
| Kosaka, A; Matsuda, I; Mori, K; Ohara, M; Shikata, A; Tukamoto, H; Yamada, S; Yamazaki, M; Yoneyama, Y | 1 |
| Herman, ZS; Machalski, M; Scieszka, M; Zielinski, M | 1 |
| Carpini, RD; Fedier, A; Fink, D; Haller, U; Schwarz, VA; Walt, H | 1 |
| Majima, T; Nakajima, T; Nozu, S; Okayasu, K; Saitou, AY; Yagi, A | 1 |
| Caporale, A; Franchi, F; Gargano, L; Konstantatoy, E; Marcellini, M; Masciangelo, R; Menichetti, ET; Seminara, P | 1 |
| Kouri, M; Kuusela, P; Pyrhönen, S | 1 |
| Herweijer, H; Nooter, K; Oosterom, R; Planting, AS; Seynaeve, C; Stoter, G; van der Burg, ME; Verweij, J | 1 |
| Falkson, G; Vorobiof, DA | 1 |
1 review(s) available for epirubicin and Colorectal Neoplasms
| Article | Year |
|---|---|
[Complications of hepatic artery chemotherapy for liver metastases in colorectal cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Arterial Occlusive Diseases; Cholangitis, Sclerosing; Cisplatin; Colorectal Neoplasms; Epirubicin; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Mitomycin; Nausea; Peptic Ulcer; Vomiting | 2003 |
15 trial(s) available for epirubicin and Colorectal Neoplasms
| Article | Year |
|---|---|
A phase II study of Epirubicin in oxaliplatin-resistant patients with metastatic colorectal cancer and TOP2A gene amplification.
Topics: Adult; Antigens, Neoplasm; Colorectal Neoplasms; Disease-Free Survival; DNA Topoisomerases, Type II; DNA-Binding Proteins; Epirubicin; Female; Gene Amplification; Humans; In Situ Hybridization, Fluorescence; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Poly-ADP-Ribose Binding Proteins; Prognosis | 2016 |
Stop-flow technique for loco-regional delivery of high dose chemotherapy in the treatment of advanced pelvic cancers.
Topics: Adolescent; Adult; Aged; Anthracyclines; Antibiotics, Antineoplastic; Chemotherapy, Cancer, Regional Perfusion; Colorectal Neoplasms; Doxorubicin; Epirubicin; Female; Humans; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Neoplasm Staging; Pelvic Neoplasms; Treatment Outcome | 2004 |
Hepatic intra-arterial chemotherapy (HIAC) of high dose mitomycin and epirubicin combined with caval chemofiltration versus prolonged low doses in liver metastases from colorectal cancer: a prospective randomized clinical study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Epirubicin; Filtration; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Mitomycin; Prospective Studies; Survival Rate | 2004 |
Oxaliplatin, 5-fluorouracil/leucovorin and epirubicin as first-line treatment in advanced gastric carcinoma: a phase II study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Colorectal Neoplasms; Epirubicin; Female; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Prognosis; Survival Rate | 2007 |
[Experience in intra-hepatic-arterial chemotherapy and hepatic resection for metastatic colorectal cancer].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Hepatectomy; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Prognosis | 1995 |
[A randomized trial of intrahepatic infusion chemotherapy for unresectable colorectal liver metastases. Sendai Study Group].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Doxorubicin; Epirubicin; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Survival Rate | 1993 |
[Clinical evaluation of hepatic arterial infusion chemotherapy in patients with liver metastases from colorectal cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colorectal Neoplasms; Doxorubicin; Drug Administration Schedule; Epirubicin; Fluorouracil; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Middle Aged; Survival Rate | 1996 |
Thymidylate synthase is a predictor for response and resistance in hepatic artery infusion chemotherapy.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Colorectal Neoplasms; Drug Administration Schedule; Drug Resistance, Neoplasm; Epirubicin; Female; Floxuridine; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Leucovorin; Liver Neoplasms; Male; Middle Aged; Mitoxantrone; Polymerase Chain Reaction; Predictive Value of Tests; Prognosis; RNA, Messenger; Survival Rate; Thymidylate Synthase; Transcription, Genetic | 1997 |
Epirubicin has modest single-agent activity in head and neck cancer but limited activity in metastatic melanoma and colorectal cancer: phase II studies by the Eastern Cooperative Oncology Group.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Colorectal Neoplasms; Epirubicin; Female; Head and Neck Neoplasms; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local | 1998 |
[Efficacy of intra-arterial chemotherapy on life prolongation in patients with hepatic metastasis from colorectal cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colorectal Neoplasms; Combined Modality Therapy; Doxorubicin; Drug Administration Schedule; Epirubicin; Fluorouracil; Hepatectomy; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Survival Rate | 1999 |
Raltitrexed (Tomudex) in combination with platinum-based agents and/or anthracyclines: preliminary results of phase I clinical trials.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colorectal Neoplasms; Digestive System Neoplasms; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Humans; Mesothelioma; Organoplatinum Compounds; Oxaliplatin; Quinazolines; Thiophenes; Treatment Outcome | 1999 |
[Arterial infusion chemotherapy for liver metastases from colorectal cancer--therapeutic effects of different protocols].
Topics: Antineoplastic Agents; Cisplatin; Colorectal Neoplasms; Doxorubicin; Drug Administration Schedule; Epirubicin; Fluorouracil; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Middle Aged; Survival Rate | 2000 |
Epirubicin, cisplatin and continuous-infusion 5-fluorouracil (ECF regimen) in the treatment of advanced colorectal cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colorectal Neoplasms; Disease-Free Survival; Epirubicin; Female; Fluorouracil; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Treatment Outcome | 2001 |
Elevated CA19-9 as the most significant prognostic factor in advanced colorectal carcinoma.
Topics: Adult; Antigens, Tumor-Associated, Carbohydrate; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoembryonic Antigen; Colorectal Neoplasms; Epirubicin; Female; Fluorouracil; Humans; Male; Methotrexate; Neoplasm Staging; Prognosis; Survival Analysis | 1992 |
A phase II study of epidoxorubicin in colorectal cancer and the use of cyclosporin-A in an attempt to reverse multidrug resistance.
Topics: Adult; Aged; Colorectal Neoplasms; Cyclosporins; Drug Resistance; Epirubicin; Female; Flow Cytometry; Humans; In Vitro Techniques; Leukopenia; Male; Middle Aged | 1991 |
21 other study(ies) available for epirubicin and Colorectal Neoplasms
| Article | Year |
|---|---|
Combination treatment of bortezomib and epirubicin increases the expression of TNFRSF10 A/B, and induces TRAIL-mediated cell death in colorectal cancer cells.
Topics: Apoptosis; Bortezomib; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Colorectal Neoplasms; Epirubicin; Humans; Receptors, TNF-Related Apoptosis-Inducing Ligand; TNF-Related Apoptosis-Inducing Ligand | 2023 |
Regulation of Fas in response to bortezomib and epirubicin in colorectal cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Bortezomib; Cell Death; Cell Line, Tumor; Colorectal Neoplasms; Dose-Response Relationship, Drug; Drug Therapy, Combination; Epirubicin; Fas Ligand Protein; fas Receptor; HCT116 Cells; Humans; RNA | 2020 |
New use for old drugs: Epirubicin in colorectal cancer.
Topics: Colonic Neoplasms; Colorectal Neoplasms; Epirubicin; Humans; Pharmaceutical Preparations | 2021 |
Expression profiles of Natural Killer Group 2D Ligands (NGK2DLs) in colorectal carcinoma and changes in response to chemotherapeutic agents.
Topics: Antineoplastic Agents; Bortezomib; Cell Line, Tumor; Colorectal Neoplasms; Databases, Genetic; Epirubicin; Gene Expression; Histocompatibility Antigens Class I; Humans; Immunotherapy; Killer Cells, Natural; Ligands; Lymphocyte Activation; NK Cell Lectin-Like Receptor Subfamily K; Receptors, Natural Killer Cell; Transcriptome | 2021 |
Modulation of the mRNA-binding protein HuR as a novel reversal mechanism of epirubicin-triggered multidrug resistance in colorectal cancer cells.
Topics: Antibiotics, Antineoplastic; Apoptosis; Blotting, Western; Cell Line, Tumor; Colorectal Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; ELAV-Like Protein 1; Epirubicin; Gene Silencing; Humans; Multidrug Resistance-Associated Proteins; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction | 2017 |
Galectin-3 silencing inhibits epirubicin-induced ATP binding cassette transporters and activates the mitochondrial apoptosis pathway via β-catenin/GSK-3β modulation in colorectal carcinoma.
Topics: Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; bcl-2-Associated X Protein; beta Catenin; Caco-2 Cells; Caspases; Cell Cycle; Cell Line, Tumor; Colorectal Neoplasms; Cyclin D1; Epirubicin; Galectin 3; Gene Silencing; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Mitochondria; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-myc; RNA, Messenger; RNA, Small Interfering; Signal Transduction | 2013 |
Evaluation of epirubicin in thermogelling and bioadhesive liquid and solid suppository formulations for rectal administration.
Topics: Acrylic Resins; Administration, Rectal; Animals; Antibiotics, Antineoplastic; Biological Availability; Cell Line, Tumor; Cell Survival; Chemistry, Pharmaceutical; Colorectal Neoplasms; Epirubicin; Gels; Half-Life; Intestinal Mucosa; Male; Mice; Mice, Inbred BALB C; Poloxamer; Rats; Rats, Sprague-Dawley; Transplantation, Heterologous | 2013 |
Infections of Blastocystis hominis and microsporidia in cancer patients: are they opportunistic?
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Blastocystis hominis; Breast Neoplasms; Colorectal Neoplasms; Cyclophosphamide; Epirubicin; Feces; Female; Fluorouracil; Humans; Leucovorin; Life Style; Malaysia; Male; Microsporidia; Middle Aged; Opportunistic Infections; Organoplatinum Compounds; Oxaliplatin; Surveys and Questionnaires | 2012 |
[Hepatic metastases from alpha-fetoprotein producing colorectal cancer that responded remarkably to transcatheter arterial chemo-embolization].
Topics: alpha-Fetoproteins; Antibiotics, Antineoplastic; Chemoembolization, Therapeutic; Colonic Neoplasms; Colorectal Neoplasms; Epirubicin; Female; Humans; Immunohistochemistry; Iodized Oil; Liver Neoplasms; Middle Aged | 2002 |
[Validity of two-hour continuous hepatic arterial infusion chemotherapy with low-dose 5-FU for unresectable liver metastasis from colorectal cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Administration Schedule; Epirubicin; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Middle Aged; Mitomycin; Prognosis; Reproducibility of Results; Survival Rate | 2003 |
A longterm follow-up study of thymidylate synthase as a predictor for survival of patients with liver tumours receiving hepatic arterial infusion chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Prognosis; Survival Analysis; Thymidylate Synthase; Treatment Outcome | 2004 |
Direct assessment of drug penetration into tissue using a novel application of three-dimensional cell culture.
Topics: Anthracyclines; Antibiotics, Antineoplastic; Colorectal Neoplasms; Daunorubicin; Doxorubicin; Epirubicin; HCT116 Cells; Humans; Hydrogen-Ion Concentration; Kinetics; Mitoxantrone; Spectrometry, Fluorescence; Tumor Cells, Cultured | 2004 |
[Home therapy approach in cancer patients-chemotherapy (case 2-3)--intra-arterial infusion cancer chemotherapy for hepatic metastasis of colorectal cancer--case report].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoembolization, Therapeutic; Cisplatin; Colorectal Neoplasms; Epirubicin; Female; Fluorouracil; Home Infusion Therapy; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Mitomycin | 1994 |
Regional adjuvant chemotherapy after partial hepatectomy for metastatic colorectal carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Catheters, Indwelling; Chemotherapy, Adjuvant; Colorectal Neoplasms; Doxorubicin; Epirubicin; Female; Fluorouracil; Hepatectomy; Hepatic Artery; Humans; Injections, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Prognosis; Survival Rate | 1997 |
[Combined intra-arterial locoregional and systemic treatment of nonresectable hepatic metastases of colorectal carcinoma].
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antidotes; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Epirubicin; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Leucovorin; Liver Neoplasms; Male; Middle Aged; Mitomycin; Time Factors | 1997 |
[Hepatic arterial chemotherapy for liver cancer over a period of 8 years].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colorectal Neoplasms; Epirubicin; Female; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Stomach Neoplasms; Survival Rate | 1997 |
Theoretical considerations and in vitro concentration response studies with two human colorectal carcinoma cell lines. The rational experimental base for clinical studies in regional chemotherapy.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Carcinoma; Cisplatin; Colorectal Neoplasms; Doxorubicin; Epirubicin; Floxuridine; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Melphalan; Mitomycin; Mitoxantrone; Tumor Cells, Cultured | 2000 |
Quality of life in cancer patients treated by chemotherapy.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Cisplatin; Colorectal Neoplasms; Epirubicin; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Lung Neoplasms; Male; Middle Aged; Neoplasms; Quality of Life; Stomach Neoplasms; Surveys and Questionnaires | 2000 |
Resistance to topoisomerase poisons due to loss of DNA mismatch repair.
Topics: Adaptor Proteins, Signal Transducing; Adenocarcinoma; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Base Pair Mismatch; Breast Neoplasms; Carrier Proteins; Colorectal Neoplasms; Deoxycytidine; DNA Repair; DNA-Binding Proteins; Docetaxel; Doxorubicin; Drug Resistance, Neoplasm; Endometrial Neoplasms; Enzyme Inhibitors; Epirubicin; Female; Gemcitabine; Humans; Intercalating Agents; Mitoxantrone; MutL Protein Homolog 1; MutS Homolog 2 Protein; Neoplasm Proteins; Nuclear Proteins; Paclitaxel; Proto-Oncogene Proteins; Taxoids; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors | 2001 |
[Clinical effectiveness of intra-arterial chemotherapy combined with degradable starch microspheres (DSM) for liver metastases and prediction of effectiveness by diagnostic imaging].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoembolization, Therapeutic; Colorectal Neoplasms; Epirubicin; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Mitomycin; Starch; Stomach Neoplasms; Tomography, X-Ray Computed | 2001 |
Phase II study of high-dose 4'-epidoxorubicin in the treatment of advanced gastrointestinal cancer.
Topics: Adult; Aged; Colorectal Neoplasms; Drug Evaluation; Epirubicin; Female; Humans; Male; Middle Aged; Stomach Neoplasms | 1989 |